Brookstone Capital Management »

Humacyte shares owned by Brookstone Capital Management

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Brookstone Capital Management from 13F filings

Historical chart of Brookstone Capital Management investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Brookstone Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Brookstone Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $21k 12k 1.74
2025-06-30 $25k 12k 2.09
2025-03-31 $20k 12k 1.71
2024-12-31 $56k 11k 5.05

More positions owned by Brookstone Capital Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Northern Lts Fd Tr Iv Brookstone Grwth (BAMG)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Northern Lts Fd Tr Iv Brookstone Divid (BAMD)
Northern Lts Fd Tr Iv Brookstone Value (BAMV)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Ishares Tr Msci Usa Min Vol (USMV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Brookstone Capital Management

Top funds holding Humacyte

BlackRock
Vanguard Group
Geode Capital Management
State Street Corporation
UBS Group
Woodline Partners
Susquehanna International
Morgan Stanley
Two Sigma Investments
Millennium Management
Citadel Advisors
Northern Trust
Private Advisor
Charles Schwab Investment Management
Marshall Wace

View all funds holding Humacyte